Coronavirus: Protein treatment trial 'a breakthrough'.

[2greys]

The preliminary results of a clinical trial suggest a new treatment for Covid-19 dramatically reduces the number of patients needing intensive care, according to the UK company that developed it.

The treatment from Southampton-based biotech Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection.

The protein is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune response.

The initial findings suggest the treatment cut the odds of a Covid-19 patient in hospital developing severe disease - such as requiring ventilation - by 79%.

bbc.co.uk/news/health-53467022

[Hidden]

so good to hear, thanks 2g

[Tugun]

Hi,

Great news and not just for Coronavirus.

[Corin1950]

That’s a very high percentage!

Some good news at last.

Hope you and Sharon are keeping well

X

[pegbl]

That's a good result. Xx

[Ergendl]

Wow, big game changer.

[Kristicats]

Interferon was a clinical trial? To reduce respiratory infection in COPD and asthma was it not?

[2greys in reply to Kristicats]

Yes it was, last year trials were conducted for those admitted with exacerbations. Since repurposed as a trial with Covid-19 patients. Both conducted at the University Hospital Southampton and 8 others. Synairgen who developed the treatment is also based here in Southampton.

[Kristicats in reply to 2greys]

Mmm I remember looking into it and may have volunteered if it were nearer home.

[2greys in reply to Kristicats]

youtube.com/watch?v=wqDd7ix...(Not working as expected?)